|
SLC39A10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.343300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.324000E-01 |
| Normal-vs-Stage2 |
7.814300E-02 |
| Normal-vs-Stage3 |
2.309800E-02 |
| Normal-vs-Stage4 |
1.583960E-01 |
| Stage1-vs-Stage2 |
1.596240E-01 |
| Stage1-vs-Stage3 |
3.788000E-02 |
| Stage1-vs-Stage4 |
1.972210E-01 |
| Stage2-vs-Stage3 |
7.250000E-01 |
| Stage2-vs-Stage4 |
7.600600E-01 |
| Stage3-vs-Stage4 |
9.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.965700E-02 |
| Normal-vs-AfricanAmerican |
3.683800E-02 |
| Normal-vs-Asian |
7.906000E-01 |
| Caucasian-vs-AfricanAmerican |
4.661000E-01 |
| Caucasian-vs-Asian |
3.964800E-01 |
| AfricanAmerican-vs-Asian |
3.663000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.290170E-01 |
| Normal-vs-Female |
1.367040E-04 |
| Male-vs-Female |
1.300020E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.588800E-01 |
| Normal-vs-Extreme_Weight |
6.009600E-01 |
| Normal-vs-Obese |
6.761400E-03 |
| Normal-vs-Extreme_Obese |
7.720000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.460800E-01 |
| Normal_Weight-vs-Obese |
2.007200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.833600E-01 |
| Extreme_Weight-vs-Obese |
1.617600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.867200E-01 |
| Obese-vs-Extreme_Obese |
2.412800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.395900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.824900E-04 |
| Normal-vs-Age(61-80Yrs) |
4.496600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.513400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.992030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.622300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.469960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.823600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.897630E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.463000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.062900E-03 |
| Normal-VS-Type2 PRCC |
8.955000E-01 |
| Normal-VS-KIRP CIMP |
2.494100E-02 |
| Normal-VS-Unclassified PRCC |
8.043800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.798400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.899600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.947590E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.388000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.760200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.316050E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.320800E-01 |
| Normal-vs-N1 |
3.063000E-03 |
| Normal-vs-N2 |
1.656150E-01 |
| N0-vs-N1 |
1.020080E-02 |
| N0-vs-N2 |
9.917800E-02 |
| N1-vs-N2 |
7.193800E-01 |
|
|
